Cancer Chemotherapy and Pharmacology

, Volume 10, Issue 3, pp 221–222

Therapeutic effect of vincristine, adriamycin and prednisolone (VAP) in angioimmunoblastic lymphadenopathy (AIL)

Authors

  • Abdallah S. Awidi
    • Department of Internal MedicineJordan University Hospital
  • Musleh S. Tarawneh
    • Department of PathologyJordan University Hospital
  • Mahmoud S. Abu Khalaf
    • Department of SurgeryJordan University Hospital
  • Mohammad S. Al Khateeb
    • Department of MicrobiologyJordan University Hospital
  • Samir S. Amr
    • Department of PathologyJordan University Hospital
Short Communication VAP Angioimmunoblastic Lymphadenopathy

DOI: 10.1007/BF00255768

Cite this article as:
Awidi, A.S., Tarawneh, M.S., Abu Khalaf, M.S. et al. Cancer Chemother. Pharmacol. (1983) 10: 221. doi:10.1007/BF00255768

Summary

Five patients, three males and two females, with angioimmunoblastic lymphadenopathy (AIL) are described. The two who received steroids had no response and died 2 and 6 months later. The three patients who received vincristine, adriamycin and prednisolone (VAP) went into remission early and are still in remission with a follow-up of 22–35 months. It is concluded that VAP is effective therapy in AIL.

Download to read the full article text

Copyright information

© Springer-Verlag 1983